Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: Association study and meta-analysis

Psychiatric Genetics

Volumn 13, Issue 1, 2003, Pages 1-12

  Jönsson, Erik G ^a   Flyckt, Lena ^b   Burgert, Edgar ^c   Crocq, Marc Antoine ^d   Forslund, Kaj ^a   Mattila Evenden, Marja ^a   Rylander, Gunnar ^a   Åsberg, Marie ^a   Nimgaonkar, Vishwajit L ^e   Edman, Gunnar ^f   Bjerkenstedt, Lars ^a   Wiesel, Frits Axel ^g   Sedvall, Göran C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Jakobsberg Karolinska Psychiat C   (Sweden)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Centre Hospitalier de Rouffach   (France)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f DANDERYD HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Association; Dopamine D3 receptor gene locus; Dopamine receptors; Genetics; Meta analysis; Schizophrenia

Indexed keywords

CLOZAPINE; DOPAMINE 3 RECEPTOR; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; EXON; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; GLYCINE; HOMOZYGOTE; HUMANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REFERENCE VALUES; SCHIZOPHRENIA; SERINE; SWEDEN; VARIATION (GENETICS);

EID: 0037336692     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200303000-00001     Document Type: Article

References (83)

1. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd rev ed, Washington, DC: American Psychiatric Association; p. 567.
2. Asherson P, Mant R, Holmans P, Williams J, Cardno A, Murphy K, et al. (1996). Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 1:125-132.
3. Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA, et al. (1999). Association of the Mscl polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropharmacotogy 21:17-27.
4. Cagle M, Peacock ML, Mathay JG, Sunnenberg C, Tandon R, Meltzer H, et al. (1993). Dopamine D3 receptor polymorphism in schizophrenia: importance of evaluating control subjects [Abstract]. Am J Hum Genet 53:783.
5. Chen C-H, Liu M-Y, Wei F-C, Koong F-J, Hwu H-G, Hsiao K-J (1997). Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene. Am J Med Genet 74:40-43.
6. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
7. Cordeiro Jr Q, Junqueira R, Vallada H (2001). Estudo de associação entre o polimorfismo serina-9-glicina do receptor dopaminérgico D3 e esquizofrenia. Arq Neuropsiquiatr 59:219-222.
8. Crocq M-A, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, et al. (1992). Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29:858-860.
9. Dahmen N, Müller MJ, Germeyer S, Rujescu D, Anghelescu I, Hiemke C, et al. (2001). Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients. Schizophr Res 49:223-225.
10. Di Bella D, Catalano M, Strukel A, Nobile M, Novelli E, Smeraldi E (1994). Distribution of the Mscl polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatr Genet 4:39-42.
11. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz J-C, Sokoloff P (1998). Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am J Med Genet 81:318-322.
12. Durany N, Thome J, Palomo A, Foley P, Riederer P, Cruz-Sànchez FF (1996). Homozygosity at the dopamine D3 receptor gene in schizophrenic patients. Neurosci Lett 220:151-154.
13. Ebstein RP, Macciardi F, Heresco-Levi U, Serretti A, Blaine D, Verga M, et al. (1997). Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. Hum Hered 47:6-16.
14. Eichhammer P, Albus M, Borrmann-Hassenbach M, Schoeler A, Putzhammer A, Frick U, et al. (2000). Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia. Am J Med Genet 96:187-191.
15. Erdfelder E, Faul F, Buchner A (1996). GPower: a general power analysis program. Behav Res Methods Instrum Comput 28:1-11.
16. Falk CT, Rubinstein P (1987). Haplotype relative risk: an easy reliable way to construct a proper control sample for risk calculation. Ann Hum Genet 51:227-233.
17. Flyckt L, Sydow O, Bjerkenstedt L, Edman G, Rydin E, Wiesel F-A (1999). Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res 31:113-129.
18. Flyckt LK (2001). Schizophrenia as a systemic disorder. Studies of peripheral and central biological functions [thesis]. Stockholm: Karolinska Institutet.
19. Gaitonde EJ, Morris A, Sivagnanasundaram S, McKenna PJ, Hunt DM, Mellon JD (1996). Assessment of association of D3 dopamine receptor Mscl polymorphism with schizophrenia. Analysis of symptom ratings, family history, age at onset, and movement disorders. Am J Med Genet 67:455-458.
20. Garcia-Barcelo MM, Lam LCW, Ungvari GS, Lam VKL, Tang WK (2001). Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. J Neural Transm 108:671-677.
21. Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, et al. (1994). Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Ctin Neurosci 244:26-32.
22. Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova A, Uyanik G, et al. (1996). Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet 67:63-70.
23. Grove WM, Andreasen N (1982). Simultaneous tests of many hypotheses in exploratory research. J Nerv Ment Dis 170:3-8.
24. Hawi Z, McCabe U, Straub RE, O'Neill A, Kendler KS, Walsh D, et al. (1998). Examination of new and reported data of the DRD3/Mscl polymorphism: no support for the proposed association with schizophrenia. Mol Psychiatry 3:150-155.
25. Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G, et al. (1995). Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatr Genet 5:113-116.
26. Inada T, Dobashi I, Sugita T, Inagaki A, Kitao Y, Matsuda G, et al. (1997). Search for a susceptibility locus to tardive dyskinesia. Hum Psychopharmacol Clin Exp 12:35-39.
27. Ishiguro H, Okuyama Y, Toru M, Arinami T (2000). Mutation and association analysis of the 5′ region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol Psychiatry 5:433-438.
28. Jönsson E (1997). Genetic aspects on schizophrenia and cerebrospinal fluid monoamine metabolites. Focus on association studies with candidate genes [thesis]. Stockholm: Karolinska Institutet.
29. Jönsson E, Lannfelt L, Sokoloff P, Schwartz J-C, Sedvall G (1993). Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr Scand 87:345-349.
30. Jönsson EG, Nimgaonkar VL, Zhang XR, Shaw SH, Burgert E, Crocq M-A, et al. (1999a). Trend for an association between schizophrenia and D3S1310, a marker in proximity to the dopamine D3 receptor gene. Am J Med Genet 88:352-357.
31. Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, et al. (1999b). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4:290-296.
32. Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, et al. (1999c). Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophr Res 40:31-36.
33. Jönsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC (2000). A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 34:239-244.
34. Joober R, Toulouse A, Benkelfat C, Lal S, Bloom D, Labelle A, et al. (2000). DRD3 and DAT1 genes in schizophrenia: an association study. J Psychiatr Res 34:285-291.
35. Kalsi G, Curtis D, Brynjolfsson J, Sigmundsson T, Petursson H, Butler R, et al. (1998). Tests of linkage, allelic and genotypic association between schizophrenia and the gene for the D3 dopamine receptor, DRD3. Psychiatr Genet 8:187-189.
36. Kendler KS, Diehl SR (1993). The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 19:261-285.
37. Kennedy JL, Billet EA, Macciardi FM, Verga M, Parsons TJ, Meltzer HY, et al. (1995). Association study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 60:558-562.
38. Krebs M-O, Sautel F, Bourdel M-C, Sokoloff P, Schwartz J-C, Olié J-P, et al. (1998). Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol Psychiatry 3:337-341.
39. Kremer I, Rietschel M, Dobrusin M, Mujaheed M, Murad I, Blanaru M, et al. (2000). No association between the dopamine D3 receptor Bal l polymorphism and schizophrenia in a family-based study of a Palestinian Arab population. Am J Med Genet 96:778-780.
40. Lannfelt L, Sokoloff P, Martres M-P, Pilon C, Giros B, Jönsson E, et al. (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2:249-256.
41. Laurent C, Savoye C, Samolyk D, Meloni R, Mallet J, Campion D, et al. (1994). Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia [Letter]. J Med Genet 31:260.
42. Le Coniat M, Sokoloff P, Hillon J, Martres M-P, Giros B, Pilon C, et al. (1991). Chromosomal localization of the human D3 dopamine receptor gene. Hum Genet 87:618-620.
43. Liao DL, Yeh YC, Chen HM, Chen H, Hong CJ, Tsai SJ (2001). Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology 44:95-98.
44. Lundström K, Turpin MP (1996). Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochern Biophys Res Commun 225:1068-1072.
45. Løvlie R, Daly AK, Blennerhassett R, Ferrier N, Steen VM (2000). Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients. Int J Neuropsychopharmacol 3:61-65.
46. Løvlie R, Thara R, Padmavathi R, Steen VM, McCreadie RG (2001). Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients. Mol Psychiatry 6:6-7.
47. Macciardi F, Verga M, Kennedy JL, Petronis A, Bersani G, Pancheri P, et al. (1994). An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk. Hum Hered 44:328-336.
48. Malhotra AK, Goldman D, Buchanan RW, Rooney W, Clifton A, Kosmidis MH, et al. (1998). The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Mot Psychiatry 3:72-75.
49. Mant R, Williams J, Asherson P, Parfitt E, McGuffin P, Owen MJ (1994). Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet 54:21-26.
50. Maziade M, Martinez M, Rodrigue C, Gauthier B, Tremblay G, Fournier C, et al. (1997). Childhood/early adolescence-onset and adult onset schizophrenia. Heterogeneity at the dopamine D3 receptor gene. Br J Psychiatry 170:27-30.
51. Meszaros K, Lenzinger E, Hornik K, Fureder T, Stompe T, Willinger U, et al. (2000). Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special?. Psychiatry Res 96;179-183.
52. Nanko S, Sasaki T, Fukuda R, Hattori M, Dai XY, Kazamatsuri H, et al. (1993). A study of association between schizophrenia and dopamine D3 receptor gene. Hum Genet 92:336-338.
53. Nimgaonkar VL, Zhang XR, Caldwell JG, Ganguli R, Chakravarti A (1993). Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: probable effects of family history?. Am J Med Genet 48:214-217.
54. Nimgaonkar VL, Sanders AR, Ganguli R, Zhang XR, Brar J, Hogge W, et al. (1996). Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples. Am J Med Genet 67:505-514.
55. Nöthen MM, Cichon S, Propping P, Fimmers R, Schwab SG, Wildenauer DB (1993a). Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed [Letter]. J Med Genet 30:708.
56. 4 receptor loci. Psychiatr Genet 3:89-94.
57. Ohara K, Nakamura Y, Xie DW, Ishigaki T, Deng ZL, Tani K, et al. (1996). Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia. Biol Psychiatry 40:1209-1217.
58. Petronis A (2000). The genes for major psychosis: aberrant sequence or regulation?. Neuropsychopharmacology 23;1-12.
59. Prasad S, Deshpande SN, Bhatia T, Wood J, Nimgaonkar VL, Thelma BK (1999). Association study of schizophrenia among Indian families. Am J Med Genet 88:298-300.
60. 9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases. Schizophr Res 20:181-186.
61. Rietschel M, Krauss H, Müller DJ, Schulze TG, Knapp M, Marwinski K, et al. (2000). Dopamine D3 receptor variant and tardive dyskinesia. Eur Arch Psychiatry Clin Neurosci 250:31-35.
62. 3 receptor gene-expressed variant and schizophrenia. Am J Med Genet 67:232-234.
63. Rybakowski JK, Borkowska A, Czerski PM, Hauser J (2001). Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Mol Psychiatry 6:718-724.
64. Saha N, Tsoi WF, Low PS, Basair J, Tay JSH (1994). Lack of association of the dopamine D3 receptor gene polymorphism (Ball) in Chinese schizophrenic males. Psychiatr Genet 4:201-204.
65. Scharfetter J, Chaudhry HR, Hornik K, Fuchs K, Sieghart W, Kasper S, et al. (1999). Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients. Eur Neuropsychopharmacot 10:17-20.
66. Schwartz JC, Diaz J, Pilon C, Sokoloff P (2000). Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions. Brain Res Brain Res Rev 31:277-287.
67. Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M, et al. (1999). Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 4:247-253.
68. Segman RH, Heresco-Levy U, Finkel B, Inbar R, Neeman T, Schlafman M, et al. (2000). Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility. Psychopharmacology 152:408-413.
69. Serretti A, Lattuada E, Cusin C, Lilli R, Lorenzi C, Smeraldi E (1999). Dopamine D3 receptor gene not associated with symptomatology of major psychoses. Am J Med Genet 88:476-480.
70. Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, et al. (1996). Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum Genet 97:714-719.
71. Sivagnanasundaram S, Morris AG, Gaitonde EJ, McKenna PJ, Mollon JD, Hunt DM (2000). A cluster of single nucleotide polymorphisms in the 5′-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia. Neurosci Lett 279:13-16.
72. 3) as a target for neuroleptics. Nature 347:146-151.
73. Spielman RS, McGinnis RE, Ewenst WJ (1993). Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
74. Spitzer RL, Williams JBW, Gibbon M (1986). Structured Clinical Interview for DSM-III-R - Non Patient Version (SCID-NP). New York: Biometrics Research Department, New York State Psychiatric Institute.
75. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, et al. (1998). European multicentre association study of schizophrenia - a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet 81:24-28.
76. Steen VM, Løvlie R, MacEwan T, McCreadie RG (1997). Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychiatry 2:139-145.
77. Suzuki M, Hurd YL, Sokoloff P, Schwartz J-C (1998). D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779:58-74.
78. Tanaka T, Igarashi S, Onodera O, Tanaka H, Takahashi M, Maeda M, et al. (1996). Association study between schizophrenia and dopamine D3 receptor gene polymorphism. Am J Med Genet 67:366-368.
79. van Rossum JM (1967). The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In: Brill H, Cole JO, Deniker P, Hippius H, Bradley PB (editors): 5th Collegium Internationale Neuropsychopharmacologicum. Amsterdam: Excerpta Medica; pp. 321-329.
80. Virgos C, Martorell L, Valero J, Figuera L, Civeira F, Joven J, et al. (2001). Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res 49:65-71.
81. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, et al. (1998). A meta-analysis and transmission disequilbirium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 3:141-149.
82. Woolf B (1955). On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
83. Yang L, Li T, Wiese C, Lannfelt L, Sokoloff P, Xu CT, et al. (1993). No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am J Med Genet 48:83-86.